PUBLIC COMPANY
saveINDIVIOR
USupdated 1mo ago
community read0 votes
pipeline
0
marketed
0
phase 3
0
catalysts ytd
0
approvals ytd
0
recalls ytd
0
Pipeline(0)
no pipeline products on record
Upcoming
no upcoming catalysts on record
Recent(90d)
nothing in the last 90 days
view all catalysts →🐶 Hiring Signal
News
- August biopharma layoffs impact just over 500, down 90% year over yearLast month, biotech and pharma companies making or planning workforce cuts included three whose reductions will more than halve their workforces. Blueprint Medicines’ layoffs will affect the most e…biospace · 7d ago
- 7 biopharma M&A deals where layoffs followedWorkforce cuts this year at seven companies involved in recent mergers and acquisitions will cost over 1,300 employees their jobs. Affected businesses include Arcellx and Tourmaline Bio, acquired b…biospace · 28d ago
- Lisata axes 72% of workforce following failed merger with KuvaIn addition to laying off employees, including a member of its management team, Lisata Therapeutics is also suing Kuva Labs, alleging the company breached a merger agreement.biospace · 1mo ago
- Supernus and Indivior merge to create CNS mega-company with 11 approved drugsSupernus Pharmaceuticals and Indivior Pharmaceuticals are outlining a combined expected $2.2 billion in annual revenue, plus $125 million in cost savings that will include “natural redundancies.”biospace · 1mo ago
- Update: Supernus, Indivior to merge and form CNS-focused drugmakerSupernus Pharmaceuticals and Indivior have signed an all-stock merger agreement to establish a new company that they believe could be a leader in central nervous system disease. The combined compan…endpoints · 1mo ago
comments(0)
5-min edit window · permanent after that